111 related articles for article (PubMed ID: 6508324)
1. [Immunotherapy with bestatin for acute non-lymphocytic leukemia (ANLL) in adults].
Kurita S; Ota K; Yamada K; Massaoka T; Uzuka Y; Ogawa N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2742-50. PubMed ID: 6508324
[TBL] [Abstract][Full Text] [Related]
2. [Results of follow-up studies on prognosis after immunotherapy with bestatin in acute nonlymphocytic leukemia].
Ota K; Kurita S; Yamada K; Masaoka T; Uzuka Y; Ogawa N
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1017-25. PubMed ID: 3963846
[TBL] [Abstract][Full Text] [Related]
3. [A new antitumor drug with immunomodulating activity, ubenimex (bestatin)].
Tsukagoshi S
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2385-91. PubMed ID: 3496857
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults.
Ota K; Kurita S; Yamada K; Masaoka T; Uzuka Y; Ogawa N
Cancer Immunol Immunother; 1986; 23(1):5-10. PubMed ID: 3533256
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled study of chemoimmunotherapy with bestatin of acute nonlymphocytic leukemia in adults.
Ota K; Ogawa N
Biomed Pharmacother; 1990; 44(2):93-101. PubMed ID: 2224060
[TBL] [Abstract][Full Text] [Related]
6. The effect of bestatin on patients with acute and chronic leukemia and malignant lymphoma.
Arimori S; Nagao T; Shimizu Y; Watanabe K; Komatsuda M
Tokai J Exp Clin Med; 1980 Jan; 5(1):63-71. PubMed ID: 6930119
[TBL] [Abstract][Full Text] [Related]
7. [Phase III study of bestatin in patients with malignant skin tumors. (1) Malignant melanoma].
Ikeda S; Ishihara K; Taguchi G
Gan To Kagaku Ryoho; 1985 Jan; 12(1):77-85. PubMed ID: 3881086
[TBL] [Abstract][Full Text] [Related]
8. [Aclacinomycin A and behenoyl ara-C combination chemotherapy for untreated acute non-lymphocytic leukemia].
Sampi K; Honda T; Hayashi Y; Hattori M
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2211-6. PubMed ID: 6578705
[TBL] [Abstract][Full Text] [Related]
9. Results of aggressive chemotherapy for acute nonlymphoblastic leukemia in adults.
Armitage JO; Burns CP; Dick FR; Aunan SB; Slymen DJ
Cancer Treat Rep; 1982 Nov; 66(11):1917-24. PubMed ID: 7139637
[TBL] [Abstract][Full Text] [Related]
10. [Non-lymphoblastic acute leukaemia: maintenance therapy by trial of a combination of chemo- and immunotherapy (author's transl)].
Sébahoun G; Gastaut JA; Imbert-Xeridat C; Favre R; Carcassonne Y
Nouv Presse Med; 1979 Feb; 8(9):663-5. PubMed ID: 377219
[TBL] [Abstract][Full Text] [Related]
11. Review of ubenimex (Bestatin): clinical research.
Ota K
Biomed Pharmacother; 1991; 45(2-3):55-60. PubMed ID: 1912370
[TBL] [Abstract][Full Text] [Related]
12. Maintenance management of acute nonlymphocytic leukemia.
Lewis JP; Pajak TF; Linman JW; Bateman JR
Cancer Clin Trials; 1981; 4(2):115-24. PubMed ID: 7249249
[TBL] [Abstract][Full Text] [Related]
13. Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia.
Peterson BA; Bloomfield CD; Theologides A; Kennedy BJ
Cancer Treat Rep; 1981; 65 Suppl 4():29-33. PubMed ID: 6955011
[TBL] [Abstract][Full Text] [Related]
14. Immunological and haematological monitoring in bladder cancer patients receiving adjuvant bestatin treatment following radiation therapy. A prospective randomized trial.
Blomgren H; Edsmyr F; Esposti PL; Näslund I
Biomed Pharmacother; 1984; 38(3):143-9. PubMed ID: 6383491
[TBL] [Abstract][Full Text] [Related]
15. Long-term results in non randomized patients with acute myelogenous leukemia: a single institution experience.
Deliliers GL; Annaloro C; Oriani A; Della Volpe A; Boschetti C; Cortelezzi A; Maiolo AT
Ann Ital Med Int; 1998; 13(3):146-51. PubMed ID: 9859570
[TBL] [Abstract][Full Text] [Related]
16. [Initial results of the clinical use of the immunostimulant bestatin (3-amino-2-hydroxy-4-phenylbutyryl leucine) in patients with chronic polyarthritis].
Meske S; Vogt P; Maly FE; Seitz M; Müller W
Z Rheumatol; 1985; 44(5):231-6. PubMed ID: 4082790
[TBL] [Abstract][Full Text] [Related]
17. [Bestatin therapy of chronic myelogenous leukemia].
Uzuka Y; Saito Y
Gan To Kagaku Ryoho; 1993 Feb; 20(2):207-14. PubMed ID: 8434958
[TBL] [Abstract][Full Text] [Related]
18. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.
Mehta J; Powles R; Singhal S; Horton C; Tait D; Treleaven J
Bone Marrow Transplant; 1996 Jul; 18(1):119-23. PubMed ID: 8832004
[TBL] [Abstract][Full Text] [Related]
19. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
Warrell RP; Arlin ZA; Kempin SJ; Young CW
Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
[TBL] [Abstract][Full Text] [Related]
20. [Bestatin-induced intravascular hemolysis in a patient with acute myelocytic leukemia].
Nakayama S; Yabe H; Ishikawa T; Nagai K
Rinsho Ketsueki; 1990 Jan; 31(1):66-9. PubMed ID: 2313907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
